Cargando…

Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal study

Clonal evolution of chronic lymphocytic leukemia (CLL) often follows chemotherapy and is associated with adverse outcome, but also occurs in untreated patients, in which case its predictive role is debated. We investigated whether the selection and expansion of CLL clone(s) precede an aggressive dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramassone, Alice, D’Argenio, Andrea, Veronese, Angelo, Basti, Alessio, Soliman, Shimaa Hassan AbdelAziz, Volinia, Stefano, Bassi, Cristian, Pagotto, Sara, Ferracin, Manuela, Lupini, Laura, Saccenti, Elena, Balatti, Veronica, Pepe, Felice, Rassenti, Laura Z., Innocenti, Idanna, Autore, Francesco, Marzetti, Laura, Mariani-Costantini, Renato, Kipps, Thomas J., Negrini, Massimo, Laurenti, Luca, Visone, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862808/ https://www.ncbi.nlm.nih.gov/pubmed/31744508 http://dx.doi.org/10.1186/s13045-019-0802-x

Ejemplares similares

HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia
por: Pagotto, Sara, et al.
Publicado: (2019)

Role of microRNAs in Chronic Lymphocytic Leukemia
por: Autore, Francesco, et al.
Publicado: (2023)

Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
por: Di Marco, Mirco, et al.
Publicado: (2021)

Epigenetics and MicroRNAs in Cancer
por: Ramassone, Alice, et al.
Publicado: (2018)

Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
por: Veronese, A, et al.
Publicado: (2015)

A large fraction of trisomy 12, 17p(−), and 11q(−) CLL cases carry unidentified microdeletions of miR-15a/16-1
por: Pepe, Felice, et al.
Publicado: (2022)

MicroRNAs in Autoimmunity and Hematological Malignancies
por: Marco, Mirco Di, et al.
Publicado: (2018)

The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
por: Van Dyke, Daniel L., et al.
Publicado: (2016)

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022)

MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
por: Visone, Rosa, et al.
Publicado: (2012)

Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units
por: Salvi, Gianfranco, et al.
Publicado: (2015)

Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
por: Rassenti, Laura Z., et al.
Publicado: (1997)

Genetic subclonal complexity and miR125a-5p down-regulatio identify a subset of patients with inferior outcome in low-ris CLL patients
por: Rigolin, Gian Matteo, et al.
Publicado: (2013)

MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
por: Ferracin, Manuela, et al.
Publicado: (2010)

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma
por: Lupini, Laura, et al.
Publicado: (2016)

New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
por: Laurenti, Luca, et al.
Publicado: (2016)

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Autore, Francesco, et al.
Publicado: (2021)

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort
por: Reda, Gianluigi, et al.
Publicado: (2022)

P612: ASSESSMENT OF THE DEVELOPMENT OF B CELL MALIGNANCIES IN A NOVEL MURINE MODEL CARRYING DLEU2 DELETION
por: Ramassone, Alice, et al.
Publicado: (2023)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Fresa, Alberto, et al.
Publicado: (2021)

The Use of Monoclonal Antibodies in the Treatment of Autoimmune Complications of Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2013)

Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation
por: Pagotto, Sara, et al.
Publicado: (2018)

Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
por: Hasan, Md Kamrul, et al.
Publicado: (2018)

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
por: Siddiqi, Tanya, et al.
Publicado: (2022)

PB1872: ANTIBODY RESPONSES AFTER COVID-19 VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA, EITHER TREATED OR NAÏVE. A MONOCENTRIC EXPERIENCE.
por: Innocenti, I., et al.
Publicado: (2022)

Measurable residual disease in chronic lymphocytic leukemia
por: Benintende, Giulia, et al.
Publicado: (2023)

The High-Throughput Analyses Era: Are We Ready for the Data Struggle?
por: D’Argenio, Valeria
Publicado: (2018)

Human Microbiome Acquisition and Bioinformatic Challenges in Metagenomic Studies
por: D’Argenio, Valeria
Publicado: (2018)

The Prenatal Microbiome: A New Player for Human Health
por: D’Argenio, Valeria
Publicado: (2018)

Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism
por: Hasan, Md Kamrul, et al.
Publicado: (2020)

Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
por: Efremov, Dimitar G., et al.
Publicado: (2012)

Non-linear Analysis of Scalp EEG by Using Bispectra: The Effect of the Reference Choice
por: Chella, Federico, et al.
Publicado: (2017)

Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
por: Sora, Federica, et al.
Publicado: (2021)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
por: Kleinstern, Geffen, et al.
Publicado: (2021)

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells
por: Pepe, F, et al.
Publicado: (2017)

Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL)
por: O'Hayre, M, et al.
Publicado: (2012)

Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma
por: Yu, Jian, et al.
Publicado: (2018)

Analysing linear multivariate pattern transformations in neuroimaging data
por: Basti, Alessio, et al.
Publicado: (2019)

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial
por: Bühler, A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7kfars0odllidmme57b2le2vbt